tumours which had not metastasized may be associated with a normal output of 5-HIAA.
The factors influencing tissue 5-HT levels in carcinoid tumours were then discussed. Tissue levels were usually elevated, often markedly so. This was to be expected as such tumours contain many argentiffin-positive cells rich in 5-HT. Tissue levels may afford biochemical confirmation of the histological diagnosis especially in cases where the tumour is localized and urinary 5-HlAA is not increased.
The data from twenty-nine cases of bronchial carcinoid were analysed. These tumours were capable of secreting 5-HT and may produce a typical carcinoid syndrome. On the whole, urinary 5-HIAA levels were lower than with intestinal tumours and tissue levels of 5-HT much lower, corresponding to the altered histochemical reactions in most bronchial carcinoids. The tumours were usually argentiffin-negative but argyrophil-positive.
Finally, data from a group of cases of atypical carcinoid tumour were considered. These argentiffin -negative, argyrophil -positive 76 tumours, originating in the stomach or bronchus, secrete 5-HTP instead of 5-HT. Some of the 5-HTP is decarboxylated and then further degraded to 5-HlAA. The cases were recognized by the presence of 5-HIAA, 5-HT and 5-HTP in the urine. Such cases show atypical features clinically and the urinary histamine excretion is abnormally high. The source of this histamine is uncertain as tumour histamine levels are not always raised. In one case, the atypical tumour was shown to be deficient in the enzyme, 5-HTP decarboxylase. The natural isotope 127 1 is utilized by man in such small amounts (150 !Jog/daily) that its chemical measurement is both arduous and prone to error. The introduction of the radioisotope 131 1 (half-life 8 days) enabled great advances in both diagnosis and therapy, and over fifteen years no carcinogenic risk has emerged from its widespread usage. However, recent biopsies of glands exposed to 131 1 many years previously have revealed unhealthy epithelial proliferation (Sheline et 01., 1962) . The radiosotope 132 1 (half-life 2·3 hours) is now readily available and offers the following advantages :
(i) The radiation exposure is about I/lOOth The Measurement of Normal Thyroid Activity of that with similar use of 131 1 (Einhorn, Balance studies (Dougherty et al., 1951) in the 1958).
rat have shown that the thyroidal iodine is main-(ii) Repeated tests, with insignificant back-tained in a steady state, the rate of hormone ground error, have enabled the definition secretion being constant over many days and in of the limits of individual variation, and equilibrium with iodine uptake. Thus small have improved the accuracy of tri-diurnal variations of the ten minute 132 1 uptake iodothyronine (T3) suppression and recorded in man (Einhorn, 1958) probably result thyrotrophin (TSH) tests. from varying dilutions of the radioisotope within
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the extrathyroidal 127 1 pool, which changes with meals, etc. 24 hour 13l I uptakes iron out such differences and no statistically significant variation has been detected in humans with season, sex or age up to fifty years (Quimby et al., 1950) . Similarly 2 hours after intravenous 132 1 (Teng and Karamountjournis, 1961) , or 4 hours after oral 132 1, the neck uptake of the normal human individual shows a coefficient of variation of only 2·8 % or 3·5 %. Robertson and Falconer (961) after comparing seven parameters of the norrnal sheep's thyroid activity (including PB127I, PB 131I and urinary excretion l3lI), concluded that tho rate of radioiodine neck uptake provided the best measure of thyroid hormone secretion.
Tbe Measurement of Abnormal Thyroid Activity
Whereas in normals, the radioiodine neck uptake reaches a maximum at 24-48 hours after the dose and reflects the hormone secretion, this is not always so in disease states.
In thyrotoxicosis the turnover is much faster and peak neck uptakes occur most often at 3-5 hours after the dose (Miller et al., 1951) so that uptakes at later times may be misleading. Similarly the 48 hours PBI3II, of little use in normals, is of established value in the diagnosis of thyrotoxicosis (Wayne, 1960) . Further, not all of the iodine taken up is secreted as active hormone (Frethem et al., 1961) , and the proportion may vary in individuals. Thus, although in a large series (Wayne, 1954 ) the extent of the 4 hours neck uptake roughly parallels the clinical severity, we sometimes see individual cases where severe thyrotoxicosis (BMR 170 %) is accompanied by a near-normal uptake (32 % dose), or conversely a high uptake (85 % dose) is found with minimal toxicity (BMR 116%).
In some 70 %of cases of hypopituitarism it is clear that the thyroid gland although capable of maintaining a radioiodine uptake in the lower half of the normal range, nevertheless fails to secrete adequate hormones Fletcher and Besford, 1958) . In some IO% of primary hypothyroidism this dissociation can be even more marked and high radioiodine uptakes are found with failure of hormone synthesis (Skillern et al., 1956; Levy et al., 1956; Buchanan et al., 1961) .
A growing source of errors in radioiodine tests arises from the use of iodine-releasing drugs and other drugs which effect thyroidal metabolism. The careful preparation of the patient which 77 precludes such errors has been described together with a list of the relevant drugs (Hobbs and Maclagan).
In straightforward clinical cases, anomalous results are obvious and their causes will usually be found. It is in the borderline cases that reliance on a single radioiodine measurement is unwise, and it is here that 132 1 in conjunction with T 3 or TSH clearly establishes its value.
bours 132 1 neck uptake
The short half-life (2,3 hours) of 132 1 restricts its use to tests within about 6 hours of its elution from a column of alumina. To this column generator, brilliantly conceived by Stang et al. (1958) , fresh supplies of the parent isotope 132 1 (half-life 77 hours) are adsorbed at two-weekly intervals. Details are available from the Radiochemical Centre, Amersham, Herts., and the annual cost is only £160 for a continuous supply of 1321.
The choice of neck uptake measured 4 hours after a I~20 floc oral dose offers the following advantages :
(i) The implications of intravenous dosage are avoided.
(ii) The effects of delayed absorption are minimized (Foote and Maclagan, 1951) .
(iii) The 13lI uptake at 4 hours is already established as the best time for discriminating most thyrotoxics from normals (Wayne, 1954) .
(iv) Convenient timing to patient and observer (dose IO a.m., test 2 p.m.).
(v) There are still 2 hours in hand to observe the effects of perchlorate, where desired (Morgans and Trotter, 1957; Koutras et al., 1960 The response is judged as follows :
(i) Normal suppression, the second uptake is below 11% of the dose, excludes a diagnosis of thyrotoxicosis. (ii) Absent suppression, the two uptakes do not differ significantly, i.e. their difference does not exceed 14% of their mean (4x coefficient of variation, 3·5 %). This finding affords 500: 1 confirmation of thyrotoxicosis (Hales et al., 1961a) et al., 1959) Anomalous uptakes iatrogenic factors < 11% dose heart failure old age
We have not determined our own normal ranges in childhood or pregnancy because we feel that here especially there is the need for the added confirmation of further tests. The great advantage of 132 1 is that borderline or anomalous results can be clarified by repeating the test after T 3 or TSH.
Children ..
Euthyroid ranges
Adults < 70 years T 3 Suppression Test hypothyroidism (Fig. 4) , a more important use of the test seems to be in the detection of subclinical hypothyroidism while the uptake is still in the normal range (Jefferies et al., 1953 Schneeberg et al., 1954) . Fig. 3 illustrates how Einhorn's (I 958) excellent studies (only possible with 132 1) have guided the design of our TSH test. The second uptake occurs wholly in the phase of peak activity, and the normal range is 35-56 % dose (mean 45'7, SO 5'3) irrespective of the initial normal uptake. This ability to exceed a control level represents what has been called the thyroid reserve (Jefferies et al., 1953) .
A gland with persistent subnormal hormone secretion acting on a normal pituitary will be driven to the limit of its reserves by endogenous TSH and will be incapable of responding further to exogenous TSH and may even show a refractory fall in 132 1 uptake. With an initial average uptake of 20 %dose the 95 %confidence limits of reproducibility would be ±2'8 % dose (4 X coefficient of variation 3·5 %). Thus a gland which fails to show a rise of more than 3 %dose after TSH is defined as showing no thyroid reserve. This finding indicates primary hypothyroidism, and the sixteen such cases shown in Fig. 4 had equivocal results to the BMR, ECG, serum cholesterol and 4 hours 132 1 neck uptake, and could only finally be diagnosed by their response to thyroxine therapy (Hobbs and Maclagan).
A rise in uptake exceeding 3 %dose but failing to gain the lower limit of the normal range, 35 % dose, is defined as a low thyroid reserve. This finding is to be expected in many patients after 1311 therapy (Martin and Stanbury, 1955) , some patients after partial thyroidectomy (Eckert et 42 48 al., 1961) and in some elderly patients; and in all of these can persist with euthyroidism for many years ). However any 25 iu TSH,m synthesized abnormal iodoproteins (Kahn et al., 1962) . (iii) Partial suppression, a significant fall but with the second uptake above II %dose. This is found in some non-toxic nodular goitres (Werner, 1955) , most patients treated with 131 1 (Werner, 1956; Hales et al., 1961b) and some patients after partial thyroidectomy (Eckert et al., 1961) . It indicates partial thyroid autonomy but with insufficient hormone secretion to produce maximal pituitary inhibition, so that some of the iodide uptake is controlled by TSH feedback. It may represent a transition from absent to normal, though can persist for years (see Fig. 4 ). This finding would seem to indicate a need for continued observation of the patient.
TSH Test
Although TSH tests can be used to distinguish the subnormal uptakes of primary and pituitary TSH TEST METHOD USING 4HR,132J NECK UPTAKE case of low thyroid reserve with symptoms suggestive of myxoedema is worth a trial of thyroxine and four such patients (Fig. 4) were proven to be hypothyroid. Others should be followed at intervals, for all too often myxoedema is diagnosed too late.
Where uptakes rise to 35-56 % dose, showing euthyroid reserve, primary hypothyroidism is excluded. In normals (even while misdirected thyroxine therapy continues, Jefferies et al., 1953) , this is achieved after the first dose of TSH (e.g. 8-48-49 % dose). 132 1 allows easy daily measurements and a stepwise response (e.g.
12-19-35-46 % dose) is a useful indication of hypopituitarism (Hobbs and Maclagan).
Conclusion
The real proof of any proposed diagnostic technique comes with borderline cases, which represent about 10 % of cases of thyrotoxicosis and about 40 % of hypothyroidism (Hobbs and Maclagan). In our experience the T 3 suppression test for thyrotoxicosis and the TSH test for hypothyroidism are among the most valuable procedures in borderline cases. They usually show an all or none response, presumably because the individual's own pituitary sets the individual's own upper and lower limits of thyroid hormone levels.
The use of 132 1 seems to be particularly desirable for these tests, even indicating when the pituitary is not working.
